Recent Webinars
-
The Stakeholder Impact of Centralized Trial Services
5/21/2026
Real‑world experiences show how centralizing logistics and payments streamlines coordination, reduces site burden, and improves trial execution.
-
Integrating Clinical Operations And Pharmacovigilance for Safer Trials
5/19/2026
Learn how integrated planning strengthens decision-making, reduces downstream risk, and supports patient safety while protecting timelines in high-risk studies.
-
AI Meets Informed Consent: Opportunity, Risk, and What IRBs Need to See
5/14/2026
Expert perspectives on IRB oversight, health literacy, and research ethics offer practical guidance to strengthen consent, protect participants, and align compliance with real-world research.
-
Applying AI to Study Simulation: From Design to Analysis
5/12/2026
See how AI-generated synthetic patient populations can mirror real trial outcomes, enabling teams to test assumptions, refine protocols, and anticipate variability early — helping reduce risk, cost, and time while improving study design decisions.
-
Execution Without Direction: The Hidden Risk In Outsourced Clinical Trials
4/29/2026
Follow along as industry experts unpack the underlying causes of these challenges and consider whether clinical oversight monitors represent a necessary evolution or simply an additional layer of complexity.
-
How To Improve Patient ID And Retention In Chronic Disease Trials
4/23/2026
Leveraging primary care for chronic disease studies can accelerate patient identification, access to underrepresented populations, and improve retention rates.
-
We Mapped What Sites Actually Do to Prepare Source Docs - The Results Are Eye-Opening
4/21/2026
New global research shows how sites prepare source documents, where inefficiencies occur, and why workflows differ — highlighting ways to streamline processes, cut delays, and improve data quality.
-
The Phase 2 Endpoint Dilemma
3/31/2026
Phase 2 neuro endpoints can miss subtle change. Learn when composites help or hinder, how to align cognition, function, and biomarkers with real-world data for go/no-go decisions.
-
Qualified eSignature in Electronic Consent Systems
2/25/2026
This on‑demand session offers a clear, practical overview of the major eSignature types used in eConsent — ranging from simple electronic signatures to fully qualified electronic signatures — and explains when each is appropriate.
-
Charting The Path To First-In-Human: Strategic Readiness For Early Clinical Success
2/10/2026
Gain a comprehensive, end-to-end perspective on the journey to first-in-human and understand how early decisions influence downstream success.